𝔖 Bobbio Scriptorium
✦   LIBER   ✦

087 POTENTIATION OF SLEEP BENEFIT BY LONG-ACTING DOPAMINE AGONIST IN PARKINSON'S DISEASE

✍ Scribed by S. Katayama

Book ID
117775946
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
60 KB
Volume
10
Category
Article
ISSN
1389-9457

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Long-term tolerability and efficacy of c
Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease
✍ R. Inzelberg; P. Nisipeanu; M. J. Rabey; Prof. A. D. Korczyn πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 333 KB πŸ‘ 2 views

## Abstract Motor fluctuations constitute a severe complication of chronic levodopa therapy. The addition of dopamine agonists may partially alleviate these responses; however, due to the short half‐lefe of these drugs, several daily doses are required. Cabergoline is a new dopamine agonist with a

Long-standing paraphilia induced by dopa
Long-standing paraphilia induced by dopamine agonists in Parkinson's disease
✍ Fanny Pineau; Michael SchΓΌpbach; Jean-Christophe Corvol; Constance Flamand-Rouvi πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 273 KB πŸ‘ 1 views

We appreciate the careful reading of our manuscript by Okun and colleagues. 1 However, their letter contains a number of inaccuracies that require correction. We clearly state